Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion.
about
Kallikrein-kinin in stem cell therapyTreatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signaling.Preclinical research into basic mechanisms of radiation-induced heart disease.Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin.Bradykinin inhibits oxidative stress-induced cardiomyocytes senescence via regulating redox state.Exercise training can prevent cardiac hypertrophy induced by sympathetic hyperactivity with modulation of kallikrein-kinin pathway and angiogenesis.Relation of plasma tissue kallikrein levels to presence and severity of coronary artery disease in a Chinese population.Synergistic effect of a tissue kallikrein 1 and tissue inhibitor of matrix metalloproteinase 1 co‑expression vector on the proliferation of rat vascular smooth muscle cells.Experimental radiation-induced heart disease: past, present, and future.Cardiac inflammation after local irradiation is influenced by the kallikrein-kinin systemKallikrein-related peptidase 8 is expressed in myocardium and induces cardiac hypertrophy.Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing.Post-infarct sleep disruption and its relation to cardiac remodeling in a rat model of myocardial infarction.Transforming growth factor β: A potential biomarker and therapeutic target of ventricular remodeling.Increased Age-Related Cardiac Dysfunction in Bradykinin B2 Receptor-Deficient Mice.Nebivolol reduces experimentally induced warm renal ischemia reperfusion injury in rats.Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review).VEGF165 attenuates the Th17/Treg imbalance that exists when transplanting allogeneic skeletal myoblasts to treat acute myocardial infarction.
P2860
Q27010386-A1F6F2FC-F96C-4B0C-B48B-A3D3AB8EA8C7Q33392798-E7DEAE8F-E7CD-4609-A4D2-C84C49E0220DQ34189520-F765D2BF-F330-4A5E-A998-179DB20D6113Q34609588-92D47064-36D3-442C-A064-C5AF64074B99Q35034973-BF5747E2-53FF-42EA-91D6-BE5027DB897CQ35116618-EFA5E172-9C8C-48F9-A262-72ABF5A25B44Q35120196-38021D2A-646A-480E-B338-779EB2749A0AQ36089841-B56505F0-7BAF-4620-905B-F2E03DF287A5Q36175827-3E0F1F1A-89C5-4EFE-A89E-23091B5C11ECQ36296024-C264B6EE-6627-418E-8E2D-6DFAECF04784Q36517193-10A01363-7ABF-48EA-BF4F-EE24CF3095DEQ37697813-C3CA6560-670A-40D2-AA82-73529FC411C8Q38982144-A552E3EA-AE99-4C1B-8D35-7819856551B9Q41593391-53BED349-5C79-4901-8D86-CD156B4F40D6Q41752395-DD8C9962-5EE1-47C6-A3E6-C7EBCA7D14B3Q46313772-CFFF63B0-F4B5-4114-BF34-992DA36B5505Q47554530-87939F5E-3635-405F-8D63-FB9B26FDC624Q54291226-E5C44328-E8CC-4BCC-87B6-3F22C05EDD22
P2860
Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Nitric oxide mediates cardiac ...... ocardial ischemia/reperfusion.
@ast
Nitric oxide mediates cardiac ...... ocardial ischemia/reperfusion.
@en
type
label
Nitric oxide mediates cardiac ...... ocardial ischemia/reperfusion.
@ast
Nitric oxide mediates cardiac ...... ocardial ischemia/reperfusion.
@en
prefLabel
Nitric oxide mediates cardiac ...... ocardial ischemia/reperfusion.
@ast
Nitric oxide mediates cardiac ...... ocardial ischemia/reperfusion.
@en
P2093
P2860
P1433
P1476
Nitric oxide mediates cardiac ...... ocardial ischemia/reperfusion.
@en
P2093
P2860
P304
P356
10.1016/J.LFS.2007.10.021
P407
P577
2007-11-09T00:00:00Z